{"count": 3, "results": [{"_id": "33461474", "pmid": 33461474, "title": "Antineoplastic Activity of an Old Natural Antidiabetic Biguanide on the Human Thyroid Carcinoma Cell Line.", "journal": "Anticancer Agents Med Chem", "authors": ["Nozhat Z", "Zarkesh M", "Baldini E", "Mohammadi-Yeganeh S", "Azizi F", "Hedayati M"], "date": "2022-01-01T00:00:00Z", "doi": "10.2174/1871520621666210118093532", "meta_date_publication": "2022", "meta_volume": "22", "meta_issue": "4", "meta_pages": "713-720", "score": 50262.06, "text_hl": "RESULTS: Results showed that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@ significantly decreased the viability of the @<m>DISEASE_Thyroid_cancer_medullary</m> @DISEASE_MESH:C536914 @@@MTC@@@ cells. ", "citations": {"NLM": "Nozhat Z, Zarkesh M, Baldini E, Mohammadi-Yeganeh S, Azizi F, Hedayati M. Antineoplastic Activity of an Old Natural Antidiabetic Biguanide on the Human Thyroid Carcinoma Cell Line. Anticancer Agents Med Chem. 2022;22(4):713-720. PMID: 33461474", "BibTeX": "@article{33461474, title={Antineoplastic Activity of an Old Natural Antidiabetic Biguanide on the Human Thyroid Carcinoma Cell Line.}, author={Nozhat Z and Zarkesh M and Baldini E and Mohammadi-Yeganeh S and Azizi F and Hedayati M}, journal={Anticancer Agents Med Chem}, volume={22}, number={4}, pages={713-720}}"}}, {"_id": "22389381", "pmid": 22389381, "title": "Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells.", "journal": "Endocr Relat Cancer", "authors": ["Klubo-Gwiezdzinska J", "Jensen K", "Costello J", "Patel A", "Hoperia V", "Bauer A", "Burman KD", "Wartofsky L", "Vasko V"], "date": "2012-05-24T00:00:00Z", "doi": "10.1530/ERC-12-0046", "meta_date_publication": "2012 Jun", "meta_volume": "19", "meta_issue": "3", "meta_pages": "447-56", "score": 50073.074, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ inhibits growth and decreases resistance to anoikis in @<m>DISEASE_Thyroid_cancer_medullary</m> @DISEASE_MESH:C536914 @@@medullary thyroid cancer@@@ cells.", "citations": {"NLM": "Klubo-Gwiezdzinska J, Jensen K, Costello J, Patel A, Hoperia V, Bauer A, Burman KD, Wartofsky L, Vasko V. Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells. Endocr Relat Cancer. 2012 Jun;19(3):447-56. PMID: 22389381", "BibTeX": "@article{22389381, title={Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells.}, author={Klubo-Gwiezdzinska J and Jensen K and Costello J and Patel A and Hoperia V and Bauer A and Burman KD and Wartofsky L and Vasko V}, journal={Endocr Relat Cancer}, volume={19}, number={3}, pages={447-56}}"}}, {"_id": "24783035", "pmid": 24783035, "title": "Metformin and thyroid: an update.", "journal": "Eur Thyroid J", "authors": ["Pappa T", "Alevizaki M"], "date": "2013-03-01T00:00:00Z", "doi": "10.1159/000346248", "meta_date_publication": "2013 Mar", "meta_volume": "2", "meta_issue": "1", "meta_pages": "22-8", "score": 50060.703, "text_hl": "Concerning @DISEASE_Thyroid_Neoplasms @DISEASE_MESH:D013964 @@@thyroid cancer@@@, there is experimental evidence showing antimitogenic properties of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in differentiated and @<m>DISEASE_Thyroid_cancer_medullary</m> @DISEASE_MESH:C536914 @@@medullary thyroid cancer@@@ cells. ", "citations": {"NLM": "Pappa T, Alevizaki M. Metformin and thyroid: an update. Eur Thyroid J. 2013 Mar;2(1):22-8. PMID: 24783035", "BibTeX": "@article{24783035, title={Metformin and thyroid: an update.}, author={Pappa T and Alevizaki M}, journal={Eur Thyroid J}, volume={2}, number={1}, pages={22-8}}"}}]}